Gregory S. Basarab

2.3k citations

62 papers · 1.4k · h-index 23

Impact in

Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria

Papers in

Molecular Biology 40
- Cancer therapeutics and mechanisms 16
- Biochemical and Molecular Research 11
Organic Chemistry 20
- Carbohydrate Chemistry and Synthesis 5

Co-authors: Douglas B. Jordan (19 shared papers)Z. Wawrzak (6 shared papers)T. Lundqvist (5 shared papers)Ylva Lindqvist (3 shared papers)John P. Pierce (2 shared papers)C. Nicholas Hodge (2 shared papers)James Chen (1 shared paper)Pamela Hill (5 shared papers)
Journals: Journal of Medicinal Chemistry (11 papers)Bioorganic & Medicinal Chemistry Letters (8 papers)Biochemistry (6 papers)ACS Infectious Diseases (5 papers)Antimicrobial Agents and Chemotherapy (4 papers)
Partner nations: United States South Africa United Kingdom

In The Last Decade

Gregory S. Basarab

60 papers receiving 1.4k citations

Peers

Countries citing papers authored by Gregory S. Basarab

Since Specialization

Citations

This map shows the geographic impact of Gregory S. Basarab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory S. Basarab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory S. Basarab more than expected).

Fields of papers citing papers by Gregory S. Basarab

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory S. Basarab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory S. Basarab. The network helps show where Gregory S. Basarab may publish in the future.

Co-authors

The 25 scholars most cited alongside Gregory S. Basarab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gregory S. Basarab Line = papers co-authored together Gregory S. Basarab links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Crystal structure of scytalone dehydratase — a disease determinant of the rice pathogen, Magnaporthe grisea Structure ·T. Lundqvist, Janet Rice, C. Nicholas Hodge, Gregory S. Basarab, John P. Pierce, Ylva Lindqvist	1994	116
2	Structure-Based Design of Potent Inhibitors of Scytalone Dehydratase: Displacement of a Water Molecule from the Active Site Biochemistry ·James Chen, Simon L. Xu, Z. Wawrzak, Gregory S. Basarab, Douglas B. Jordan	1998	111
3	Pyrrolamide DNA gyrase inhibitors: Optimization of antibacterial activity and efficacy Bioorganic & Medicinal Chemistry Letters ·Brian Sherer, Kenneth G. Hull, Oluyinka Green, Gregory S. Basarab, Sheila I. Hauck, Pamela Hill, James T. Loch, G. B. MULLEN, Shanta Bist, Joanna Bryant, Ann Boriack-Sjodin, Jon Read, Nancy DeGrace, Maria Uria-Nickelsen, Ruth Illingworth, Ann E. Eakin	2011	95
4	Fragment-to-Hit-to-Lead Discovery of a Novel Pyridylurea Scaffold of ATP Competitive Dual Targeting Type II Topoisomerase Inhibiting Antibacterial Agents Journal of Medicinal Chemistry ·Gregory S. Basarab, John I. Manchester, Shanta Bist, P. Ann Boriack‐Sjodin, Brian Dangel, Ruth Illingworth, Brian Sherer, Shubha Sriram, Maria Uria-Nickelsen, Ann E. Eakin	2013	70
5	Optimization of Pyrrolamide Topoisomerase II Inhibitors Toward Identification of an Antibacterial Clinical Candidate (AZD5099) Journal of Medicinal Chemistry ·Gregory S. Basarab, Pamela Hill, C. Edwin Garner, Ken Hull, Oluyinka Green, Brian Sherer, Petra Dangel, John I. Manchester, Shanta Bist, Sheila I. Hauck, Fei Zhou, Maria Uria-Nickelsen, Ruth Illingworth, Richard A. Alm, (unknown), Ann E. Eakin	2014	64
6	In Vitro Antibacterial Activity of AZD0914, a New Spiropyrimidinetrione DNA Gyrase/Topoisomerase Inhibitor with Potent Activity against Gram-Positive, Fastidious Gram-Negative, and Atypical Bacteria Antimicrobial Agents and Chemotherapy ·Michael D. Huband, Patricia A. Bradford, Linda G. Otterson, Gregory S. Basarab, Amy Kutschke, R.A. Giacobbe, Sara A. Patey, Richard A. Alm, Michele Johnstone, Marie E. Potter, Paul Miller, John P. Mueller	2014	61
7	Discovery of Novel DNA Gyrase Inhibiting Spiropyrimidinetriones: Benzisoxazole Fusion with N-Linked Oxazolidinone Substituents Leading to a Clinical Candidate (ETX0914) Journal of Medicinal Chemistry ·Gregory S. Basarab, P. Doig, Vincent Galullo, Günther Kern, Amy Kimzey, Amy Kutschke, Joseph P. Newman, Marshall Morningstar, John P. Mueller, Linda G. Otterson, Karthick Vishwanathan, Fei Zhou, Madhusudhan Gowravaram	2015	58
8	Novel DNA Gyrase Inhibiting Spiropyrimidinetriones with a Benzisoxazole Scaffold: SAR and in Vivo Characterization Journal of Medicinal Chemistry ·Gregory S. Basarab, Patrick Brassil, P. Doig, Vincent Galullo, Howard B. Haimes, Günther Kern, Amy Kutschke, John McNulty, Virna Schuck, Gregory G. Stone, Madhusudhan Gowravaram	2014	44
9	Trihydroxynaphthalene Reductase from Magnaporthe grisea: Realization of an Active Center Inhibitor and Elucidation of the Kinetic Mechanism Biochemistry ·James E. Thompson, Gregory S. Basarab, Arnold Andersson, Ylva Lindqvist, Douglas B. Jordan	1997	41
10	Potent and selective inhibitors of Helicobacter pylori glutamate racemase (MurI): Pyridodiazepine amines Bioorganic & Medicinal Chemistry Letters ·Bolin Geng, Gregory S. Basarab, Janelle Comita-Prevoir, Madhusudhan Gowravaram, Pamela Hill, Andrew F. Kiely, James T. Loch, Lawrence MacPherson, Marshall Morningstar, G. B. MULLEN, Ekundayo Osimboni, Alexander L. Satz, Charles J. Eyermann, T. Lundqvist	2008	40
11	Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914 Journal of Biological Chemistry ·Günther Kern, Tiffany Palmer, David E. Ehmann, Adam B. Shapiro, Beth Andrews, Gregory S. Basarab, P. Doig, Jun Fan, Ning Gao, Scott D. Mills, John P. Mueller, Shubha Sriram, Jason Thresher, Grant K. Walkup	2015	40
12	Structure-based design of inhibitors of the rice blast fungal enzyme trihydroxynaphthalene reductase Journal of Molecular Graphics and Modelling ·Douglas B. Jordan, Gregory S. Basarab, Der‐Ing Liao, Wynona M. Johnson, Kevin N. Winzenberg, David A. Winkler	2001	38
13	Negamycin induces translational stalling and miscoding by binding to the small subunit head domain of the Escherichia coli ribosome Proceedings of the National Academy of Sciences ·N.B. Olivier, (unknown), J. Noeske, Gregory S. Basarab, Erin Code, Andrew D. Ferguson, Ning Gao, Jian Huang, Manuel F. Juette, Stephania Livchak, M.D. Miller, D. Bryan Prince, J.H.D. Cate, Ed T. Buurman, Scott C. Blanchard	2014	35
14	Catalytic Mechanism of Scytalone Dehydratase: Site-Directed Mutagenisis, Kinetic Isotope Effects, and Alternate Substrates Biochemistry ·Gregory S. Basarab, James J. Steffens, Z. Wawrzak, Rand S. Schwartz, T. Lundqvist, Douglas B. Jordan	1999	33
15	Identification, Characterization, and Optimization of 2,8-Disubstituted-1,5-naphthyridines as Novel Plasmodium falciparum Phosphatidylinositol-4-kinase Inhibitors with in Vivo Efficacy in a Humanized Mouse Model of Malaria Journal of Medicinal Chemistry ·Nishanth Kandepedu, Diego González Cabrera, Srinivas Eedubilli, Dale Taylor, Christel Brunschwig, Liezl Gibhard, Mathew Njoroge, Nina Lawrence, Tanya Paquet, Charles J. Eyermann, Thomas Spangenberg, Gregory S. Basarab, Leslie J. Street, Kelly Chibale	2018	33
16	Structures of Trihydroxynaphthalene Reductase-Fungicide Complexes Structure ·Der‐Ing Liao, Gregory S. Basarab, Anthony A. Gatenby, Barbara Valent, Douglas B. Jordan	2001	32
17	High-resolution structures of scytalone dehydratase-inhibitor complexes crystallized at physiological pH Proteins Structure Function and Bioinformatics ·Z. Wawrzak, Tatyana Sandalova, James J. Steffens, Gregory S. Basarab, T. Lundqvist, Ylva Lindqvist, Douglas B. Jordan	1999	31
18	Cyclobutane carboxamide inhibitors of fungal melanin: biosynthesis and their evaluation as fungicides Bioorganic & Medicinal Chemistry ·Lee D. Jennings, Dennis R. Rayner, Douglas B. Jordan, John F. Okonya, Gregory S. Basarab, Denise Amorose, Beth Anaclerio, John K. Lee, Rand S. Schwartz, Kari Ann Whitmore	2000	28
19	Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis Activity Journal of Medicinal Chemistry ·Preshendren Govender, Rudolf Müller, Kawaljit Singh, Virsinha Reddy, Charles J. Eyermann, Stephen Fienberg, Sandeep R. Ghorpade, L. Koekemoer, Alissa Myrick, Dirk Schnappinger, Curtis A. Engelhart, Jaclynn Meshanni, Jo Ann W. Byl, Neil Osheroff, Vinayak Singh, Kelly Chibale, Gregory S. Basarab	2022	28
20	Design of Helicobacter pylori glutamate racemase inhibitors as selective antibacterial agents: A novel pro-drug approach to increase exposure Bioorganic & Medicinal Chemistry Letters ·Gregory S. Basarab, Pamela Hill, Abdullah Rastagar, Peter J. H. Webborn	2008	27

About Gregory S. Basarab

Gregory S. Basarab is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Pharmacology and Ecology, Evolution, Behavior and Systematics, having authored 62 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (16 papers), Biochemical and Molecular Research (11 papers), Fungal Plant Pathogen Control (9 papers), Antibiotic Resistance in Bacteria (8 papers), Enzyme Structure and Function (7 papers), Malaria Research and Control (6 papers), Carbohydrate Chemistry and Synthesis (5 papers) and Bioactive Compounds and Antitumor Agents (5 papers). The work is most often cited by research in Toxicology (122 citations), Molecular Medicine (159 citations), Organic Chemistry (435 citations), Pharmacology (209 citations) and Molecular Biology (838 citations). Gregory S. Basarab has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Douglas B. Jordan, Z. Wawrzak, T. Lundqvist, Ylva Lindqvist, John P. Pierce, C. Nicholas Hodge, James Chen, Pamela Hill, Simon L. Xu and Rand S. Schwartz. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Biochemistry, ACS Infectious Diseases and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Gregory S. Basarab

Impact in

Papers in i

In The Last Decade

Gregory S. Basarab

Peers

Countries citing papers authored by Gregory S. Basarab

Fields of papers citing papers by Gregory S. Basarab

All Works

About Gregory S. Basarab

Explore authors with similar magnitude of impact

Papers in